Understanding urticaria through traditional medicine
Part of Immune system & allergy, Skin clinical trials.
This study looks at how traditional medicine classifies urticaria (hives) and aims to connect those patterns to what patients experience. It may help researchers better understand different types of hives and personalize treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 15 years or older
- Diagnosed with acute or chronic hives (urticaria) by a doctor
- Agree to take part and sign a consent form
- Not have other skin conditions that could be confused with hives
- Not be currently taking antihistamines, steroids, or immune-suppressing drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to better understand inducible urticaria (hives triggered by cold, pressure, or friction) and chronic spontaneous urticaria. Researchers will use skin tests to measure how different triggers affect your skin in detail.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This study tests different treatment options for people with chronic hives (urticaria) that have lasted more than 6 weeks. It aims to find which treatment works best and is safe.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests a new medication called THB335 for people with chronic spontaneous urticaria (CSU), which causes hives and itching for months without a clear cause. The study will see if the drug can reduce hives and itching better than a placebo (a pill with no active medicine).
This trial tests a new medication (HS-10561) first in healthy adults to check safety, then in people with chronic spontaneous urticaria (long-term hives without a known cause) to see if it helps reduce symptoms. It may be an option for those who have had hives for at least 6 months.
Hear when a new Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.